Exact Sciences Stock Insider Trading

Healthcare > Medical - Diagnostics & Research

Buy EXAS

*Your capital is at risk

$104.91

+0 (+0%)

At Close: Jun 22, 2026

EXACT Sciences Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 18.85. In total, the insiders bought 1.11M and sold 1.42M EXAS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	18.85
● Buy	1.11M shares
● Sell	1.42M shares
35% Buy Activity Moderate Negative Correlation
Sell Signal Low Confidence Mar 23, 2026 Analysis Breakdown: Weakened by a contradictory positive Insider Power Score. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 23, 2026 Sell	Stock Options (Right to Buy) D-Return	Herriott James SVP, General Counsel & Sec	Officer	793 Value: $73.4K
Mar 23, 2026 Sell	Stock Options (Right to Buy) D-Return	Herriott James SVP, General Counsel & Sec	Officer	2 861 Value: $280.9K
Mar 23, 2026 Sell	Restricted Stock Units D-Return	Herriott James SVP, General Counsel & Sec	Officer	20 321 Value: $0
Mar 23, 2026 Buy	Common Stock A-Award	Bloomer Aaron EVP, Chief Financial Officer	C-Suite Officer	89 911 Value: $9.43M
Mar 23, 2026 Sell	Common Stock D-Return	Bloomer Aaron EVP, Chief Financial Officer	C-Suite Officer	417 Value: $0
Mar 23, 2026 Sell	Restricted Stock Units D-Return	Bloomer Aaron EVP, Chief Financial Officer	C-Suite Officer	28 063 Value: $0
Mar 23, 2026 Buy	Common Stock A-Award	Condella Sarah EVP, Human Resources	Officer	60 389 Value: $6.34M
Mar 23, 2026 Sell	Common Stock D-Return	Condella Sarah EVP, Human Resources	Officer	6 368 Value: $0
Mar 23, 2026 Sell	Stock Options (Right to Buy) D-Return	Condella Sarah EVP, Human Resources	Officer	11 700 Value: $519.1K
Mar 23, 2026 Sell	Restricted Stock Units D-Return	Conroy Kevin T President And CEO	CEO / President	154 829 Value: $0
Mar 23, 2026 Buy	Common Stock A-Award	Orville Jacob A EVP, Gm, Screening	Officer	53 323 Value: $5.59M
Mar 23, 2026 Sell	Restricted Stock Units D-Return	Orville Jacob A EVP, Gm, Screening	Officer	38 707 Value: $0
Mar 23, 2026 Sell	Common Stock D-Return	Coward D Scott Director	Director	52 164 Value: $522
Mar 23, 2026 Sell	Stock Options (Right to Buy) D-Return	Coward D Scott Director	Director	4 175 Value: $185.2K
Mar 23, 2026 Sell	Stock Options (Right to Buy) D-Return	Coward D Scott Director	Director	10 786 Value: $999.0K
Mar 23, 2026 Sell	Stock Options (Right to Buy) D-Return	Coward D Scott Director	Director	12 875 Value: $1.26M
Mar 23, 2026 Sell	Common Stock D-Return	Petrovic Shacey Director	Director	16 406 Value: $164
Mar 23, 2026 Sell	Common Stock D-Return	Petrovic Shacey Director	Director	5 398 Value: $0
Mar 23, 2026 Sell	Common Stock D-Return	Popovits Kimberly J Director	Director	6 725 Value: $67
Mar 23, 2026 Sell	Common Stock D-Return	Clancy Paul J Director	Director	20 640 Value: $206
Mar 23, 2026 Sell	Common Stock D-Return	Clancy Paul J Director	Director	5 398 Value: $0
Mar 23, 2026 Sell	Common Stock D-Return	Barber Michael J Director	Director	5 398 Value: $0
Mar 23, 2026 Sell	Common Stock D-Return	Trigg Leslie Director	Director	3 244 Value: $32
Mar 23, 2026 Buy	Common Stock A-Award	Baranick Brian EVP, Gm, Precision Oncology	Officer	33 321 Value: $3.50M
Mar 23, 2026 Sell	Common Stock D-Return	Baranick Brian EVP, Gm, Precision Oncology	Officer	795 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT EXACT SCIENCES CORPORATION

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid th...

Read Full Profile Here